News Sara Hurvitz

(1 - 21 von 22
)

Experimental Drug T-DM1 Clinical Trials Encouraging Against...

abcnews.go.com
T-DM1, an experimental drug, showed promise in clinical trials against HER2-positive breast cancer. Patients who took the drug were free of disease longer than...

Breast cancer treatment has evolved. Here’s where we are.

healthcare-in-europe.com
There is no “one size fits all approach” when it comes to treating breast cancer. The disease is made up of several subtypes, and ideally each type should be...

Als orthodoxe Frau ins Rabbinat? | Jüdische Allgemeine

www.juedische-allgemeine.de
Meesh Hammer-Kossoy wurde im Juni in Jerusalem ordiniert. Julia Konnik entschied sich bewusst für ihre Familie

Abemaciclib effective for Ki67 reduction in certain postmenopausal...

www.healio.com
COPENHAGEN, Denmark — Neoadjuvant abemaciclib with or without anastrozole led to significantly greater reductions in tissue Ki67 after 2 weeks of...

UCLA Jonsson Comprehensive Cancer Center : Sara Hurvitz

cancer.ucla.edu
Cancer center at the University of California, Los Angeles. Dr. Sara Hurvitz leads studies aimed at improving breast cancer care.

Dignitana Receives U.S. FDA De Novo Clearance for The

www.globenewswire.com
Dignitana Receives U.S. FDA De Novo Clearance for The DigniCap® Scalp Cooling System that Reduces Hair Loss Related to Chemotherapy for Women with Breast...

Events Archive - The Simms Mann Institute & Foundation

www.simmsmanninstitute.org
Sara Hurvitz, MD. at Simms/Mann UCLA Center for Integrative Oncology Evolving Insights into the Rational Treatment of Breast Cancer September

FDA approves new breast cancer drug | University of California

www.universityofcalifornia.edu
UCLA research played key role in development of Ibrance, targeting estrogen-receptor–positive breast cancer.

Adding ribociclib to hormone therapy extends lives of women ...www.newswise.com › articles › ad...

www.newswise.com
Credit: UCLA Credit: Dr. Sara Hurvitz (left) led a study at UCLA Jonsson Comprehensive Cancer Center that found adding a drug that inhibits ...

Clinical trial seeks to help HER2-positive breast cancer patients

www.wndu.com
Targeted therapies have extended life for HER2-positive breast cancer patients for 20 years, but experts say that when the disease reaches stage 4 it spreads...

Many women with early breast cancer may not need chemo, study finds

www.nbcnews.com
Most women with early-stage breast cancer may be able to avoid chemotherapy, a new study finds.

Breast cancer treatment shows hope for younger women with advanced...

www.nbcnews.com
Younger women with the most common form of breast cancer may live longer with a treatment doctors are calling a

PARP inhibitor improves progression-free survival in patients...

www.mdanderson.org
... Sara Hurvitz, M.D., University of California, Los Angeles; Anthony Gonçalves, M.D., Ph.D., Institut Paoli-Calmettes, Marseille; Kyung-Hun Lee, ...

Drug combos could hold off advanced breast cancer, studies say - Los...

www.latimes.com
Drug combos could hold off advanced breast cancer, studies say

New breast cancer drugs show promise

www.wcax.com
Sara Hurvitz with the UCLA Jonsson Comprehensive Cancer Center. The findings, which looked at more than 200 patients, were made public at ...

UCLA Tests New Device That May Save Patient’s Hair During...

www.cbsnews.com
For many cancer patients, losing hair during chemotherapy can be especially hard during an already tough time. A new cap is being tested on breast cancer...

Tether drugs together to target breast cancer | New Scientist

www.newscientist.com
A drug that links Herceptin to a new cancer drug, DM1, targets breast cancer cells while leaving healthy ones alone

Two Potentially Breakthrough Drugs Off New Hope To People With...

www.cbsnews.com
One is able to reach tumors that have spread to the brain. The other has been described as a guided missile, a drug that's able to bring chemotherapy directly...

ecancerpatient.org - Provides information for patients to use while...

myemail.constantcontact.com
Dr. Sara Hurvitz discusses the role of PI3/AKT/mTOR inhibitors, such as Everolimus and how they help towards breast cancer treatment. Play video > ...
Verwandte Suchanfragen zu Sara Hurvitz
Kelly McCann
Personen
Vorname "Sara" (18504)
Name "Hurvitz" (28)
+1